Novel Clinical Biomarkers for Drug-Induced Liver Injury
Youhao Chen(Guangdong Pharmaceutical University), Min Huang(Sun Yat-sen University), Huichang Bi(Southern Medical University), Yanping Guan(Sun Yat-sen University), Yanying Zhou(Sun Yat-sen University), Xueding Wang(Sun Yat-sen University), Shaoxing Guan(Sun Yat-sen University), Siyuan Tang(Central South University)
Cited by 18
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126
Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1–p53 signaling pathways
|Toxicology Letters|2015|122
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation
|Chemico-Biological Interactions|2015|117